Phase 3,randomized,double-blind,clinical trial of IKH-01 for treatment of dysmenorrhea associated with endometriosis.

Authors
Category Primary study
JournalJapan Primary Registry Network
Year 2005
INTERVENTION: Intervention name : IKH‐01 Dosage And administration of the intervention : Oral CONDITION: dysmenorrhea associated with endometriosis. PRIMARY OUTCOME: Efficacy INCLUSION CRITERIA: Age limit:minimum 18years dysmenorrhea associated with endometriosis
Epistemonikos ID: f0522eaefbffaba66708999700994797c7a27a6f
First added on: Aug 21, 2024